Significance of the absolute lymphocyte/monocyte ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma

Blood Cancer J. 2017 Jun 30;7(6):e579. doi: 10.1038/bcj.2017.60.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Disease-Free Survival
  • Female
  • Humans
  • Lymphocyte Count
  • Lymphocytes* / immunology
  • Lymphocytes* / metabolism
  • Male
  • Middle Aged
  • Monocytes* / immunology
  • Monocytes* / metabolism
  • Multiple Myeloma* / blood
  • Multiple Myeloma* / immunology
  • Multiple Myeloma* / mortality
  • Survival Rate

Substances

  • Biomarkers